An article involving significant contributions from the DRCMR has just appeared in the prestigious journal The Lancet Neurology.

The article evaluates the efficacy of a new combination treatment for Multiple Sclerosis. The described international multi-center study was partially based on MR images aquired at the DRCMR at Hvidovre Hospital. The data analysis was developed and conducted in the DRCMR Reader Centre, which is an evaluation center for international drug trials involving MRI. Co-author Lise Vejby Søgaard represents the Reader Centre.

The paper can be found on the The Lancet's homepage and it is entitled

NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.